Can AstraZeneca Thrive on Its Own? Big Test Looms

The drug maker hopes the results of a trial for Mystic, a lung-cancer treatment, will prove it was right to fend off a 2014 takeover offer and commit to developing immunotherapy medicines.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News